IN VIVO STUDIES ON VIRAL VIRULENCE

Similar documents
Cristina Cassetti, Ph.D.

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study

Study Guide 23, 24 & 47

Chapter 1. Full file at

Influenza. Gwen Clutario, Terry Chhour, Karen Lee

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

Vaccines and other immunological antimicrobial therapy 1

Gene Vaccine Dr. Sina Soleimani

Quality, safety and standards for poliomyelitis vaccines

! " ## $%& &'( ) Page 1 of 7

The Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE

VACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.

BBS 2711 Virology. Virus Vaccines

The Biology of Viruses MMI / Biochem 575 SPRING 2015

PMC ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. PLoS Pathog. 2013;9(4):e PMC

EVOLUTION. Reading. Research in my Lab. Who am I? The Unifying Concept in Biology. Professor Carol Lee. On your Notecards please write the following:

Chronic Viral Infections vs. Our Immune System: Revisiting our view of viruses as pathogens

Viral vaccines. Lec. 3 أ.د.فائزة عبد هللا مخلص

Ebola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017

Primary Isolation and Cultivation of Viruses

Technology Overview. Summary

LEC 2, Medical biology, Theory, prepared by Dr. AYAT ALI

Trends in vaccinology

Practical Applications of Immunology. Chapter 18

Memory NK cells during mousepox infection. Min Fang, Ph.D, Professor Institute of Microbiology, Chinese Academy of Science

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

3. Lymphocyte proliferation (fig. 15.4): Clones of responder cells and memory cells are derived from B cells and T cells.

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

Adenovirus-mediated gene therapy against viral biothreat agents

Part I. Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents.

III. What are the requirements for taking and passing this course?

IMMUNE SYSTEM. Biology 2201

IMMUNE SYSTEM. Biology What is a disease? Other than an injury, any change in the body that interferes with the normal functioning of the body.

Replication Defective Enterovirus Infections: Implications for Type I Diabetes

Emerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors

Modeling the Effects of HIV on the Evolution of Diseases

The Immune System and Pathology

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

Immunization (I) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

The Influence of Climate Change on Insect. Director Australian Animal Health Laboratory, Geelong

SURVEILLANCE TECHNICAL

SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.

Unit 4 Student Guided Notes

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

Global Catastrophic Biological Risks

Evaluating the promise of a transmissible vaccine. Scott L. Nuismer

2000 and Beyond: Confronting the Microbe Menace 1999 Holiday Lectures on Science Chapter List

Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice October 26, 2012

Viral Pathogenesis. Pathogenesis: the process by which one organism causes disease in another Two components of viral disease:

1. Virus 2. Capsid 3. Envelope

Immunodeficiency. (2 of 2)

Chapter 19: The Genetics of Viruses and Bacteria

Lecture 2: Virology. I. Background

BBS2711 Virology. Central Nervous System (CNS) Viruses. Dr Paul Young, Department of Microbiology & Parasitology.

Innate immunity. Abul K. Abbas University of California San Francisco. FOCiS

Viral Pathogenesis. Respiratory tract. Alimentary tract

Virus-host interactions

Application of Reverse Genetics to Influenza Vaccine Development

Evolution of influenza

The Biology of Viruses MMI / Biochem 575 SPRING 2015

An Evolutionary Story about HIV

7.012 Quiz 3 Answers

Immunodeficiencies HIV/AIDS

Viruses and cancer: Should we be more afraid?

Dr. Ahmed K. Ali. Outcomes of the virus infection for the host

Vincent Racaniello

Vaccines. Vaccines ( continued 1) February 21, 2017 Department of Public Health Sciences

Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B

Acute neurological syndromes

Bacteria and Viruses

CHAPTER 18: Immune System

Viruses. Objectives At the end of this sub section students should be able to:

Opening Activity. Make a list of all the diseases and infections you have had.

LESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic

2 - Adaptive Immunity

Lecture 11. Immunology and disease: parasite antigenic diversity

Research with Dual Use Potential. Presentation Nancy Connell, Yousra Sobeih and Alastair Hay

Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines

Pathogenesis of viral infection

Pathogens and the immune system

Fill in the table about receptors. The first answer has been done for you.

1) understand the structure and life cycle of viruses as well as viral evolution. 2) know the mechanisms of host immune responses to viral infections

Immunology: an overview Lecture

Data collection on African Swine Fever virus for epidemiological analysis. Claire Guinat EFSA Worshop, Parma, Italy 2015

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination

HIV and AIDS A Global Pandemic. The basics. NM1726

INFLUENZA-2 Avian Influenza

Viral Genetics. BIT 220 Chapter 16

7.013 Spring 2005 Problem Set 7

Lecture 19 Evolution and human health

The making of Bovela - a vaccine against bovine viral diarrhea

Acquired Immunity 2. - Vaccines & Immunological Memory - Wataru Ise. WPI Immunology Frontier Research Center (IFReC) Osaka University.

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

Malaria parasite vaccine development Strategies & Targets

Pre-Assessment Review: Microbiology, Part 2: Virology. Dr. David Hillyard

Respiratory tract. Alimentary tract MID 31. Pathogenesis: the process by which one organism causes disease in another Two components of viral disease:

Chapter 6- An Introduction to Viruses*

Transcription:

IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014

Viral Virulence Capacity of a virus to cause disease in a host Virulent vs avirulent or attenuated virus A virulent strain causes significant disease An avirulent or attenuated strain causes no or reduced disease Virulence factors & mechanisms Virus-induced immune suppression Pathogenesis

In vitro Studies In vitro: taking place in a test tube, culture dish or elsewhere OUTSIDE a living organism Cell lines, primary cells Assaying genes for essentiality to invasion, survival, replication, immune modulation and cytotoxicity

In vitro Studies Excellent tools for simple questions with limited variables Cells are easily manipulated Cost efficient Scalable In vitro studies have given us a lot BUT Focus on one specific aspect of the disease process only Cannot predict relevant phenotypes associated with pathogenesis

Models Systems to Study Viral Virulence: In vitro and In vivo In vitro: cell lines, primary cells In vivo: animals models

Mice with new receptors Mice with complete viral genomes Mice expressing individual viral genes Study of virus infection and disease Study of the host response to infection Clonal T-cell receptor Immune mediator deletion Immune cell deletion Immune mediator overproduction

Human viruses in animals May need to manipulate the mouse E.g. Transgenic poliovirus receptor mouse Animal viruses that resemble human infection human receptor to poliovirus (hpvr) Transgenic poliovirus receptor mouse (TgPVR)

Virulence can be Quantitated Meantime to death Meantime to appearance of symptoms Measurement of fever, weight loss Influenza infection Measurement of pathological lesions Poliovirus infection Reduction in blood CD4+ lymphocytes HIV-1 infection

General Approach What makes type 2 virus more virulence than type 1? Are there any genetic differences that affect viral virulence? Principles of Virology, ASM Press

Virulence Genes Major goal of virology is to identify virulence genes that determine virulence Viral virulence genes involved in Viral replication Defeat host defense mechanisms Invasiveness Intrinsic cell killing effects

Virulence genes usually identified by mutation: a virus that causes reduced or no disease in a specified system Principles of Virology, ASM Press

Virulence determinant in Poliovirus Poliovirus genome

Poliovirus replication in mouse brain One base change is enough to change the virulence of poliovirus Implication: develop oral polio vaccine (OPV)

Other Factors Affecting Viral Virulence in Mice Dose Route of infection Age of host Species Gender (males slightly more susceptible to viral infections than females)

Age of host Gender Species Route of inoculation Dose Ebihara, H., Takada, A., Kobasa, D., Jones, S., Neumann, G., Theriault, S.,... & Kawaoka, Y. (2006). Molecular determinants of Ebola virus virulence in mice.plos pathogens, 2(7), e73.

Benefits and Problems of Using Animal Model Benefits Show human-like clinical signs and pathology of disease Suitable for transmission experiments, vaccine research Helps to understand some certain mechanism of disease and therapeutic agent observed in animal model. Problems Practical considerations Absence of small animal model Never mimics exactly what happens in people

Future Prospects To increase knowledge of molecular mechanism of virus replication and mechanism of pathogenesis in viral disease further. To investigate antibody enhancement of virus infection, induction of auto immunity and development of immune cell dysfunction and tumours To develop in the field of small animal models Efficacy assessment and pre-clinical evaluation of novel virus vaccine constructs

THANK YOU